Rosewell Park Comprehensive Cancer Center (Site 114) — Buffalo, New York

Rosewell Park Comprehensive Cancer Center (Site 114) is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Rosewell Park Comprehensive Cancer Center (Site 114) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC).

Sponsors: J-Pharma Co., Ltd..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rosewell Park Comprehensive Cancer Center (Site 114)?

Rosewell Park Comprehensive Cancer Center (Site 114) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rosewell Park Comprehensive Cancer Center (Site 114) conducted?

Rosewell Park Comprehensive Cancer Center (Site 114) has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC).

Is Rosewell Park Comprehensive Cancer Center (Site 114) accredited by Crixeo Health?

Rosewell Park Comprehensive Cancer Center (Site 114) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rosewell Park Comprehensive Cancer Center (Site 114)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.